An in vivo RNAi mini-screen in Drosophila cancer models reveals novel potential Wnt targets in liver cancer
- PMID: 30541713
- PMCID: PMC6408157
- DOI: 10.5152/tjg.2018.18241
An in vivo RNAi mini-screen in Drosophila cancer models reveals novel potential Wnt targets in liver cancer
Abstract
Background/aims: Aberrant activation of the Wnt/β-catenin signaling, which arises from the accumulation of mutant β-catenin in the cell, is one of the most common driving forces in hepatocellular carcinoma (HCC). We previously identified several genes that are regulated on the overexpression of β-catenin in the HCC cell line that are suggested to be novel Wnt/β-catenin targets playing effective roles in cancer. The aim of the present study was to elucidate the roles of these putative target genes in tumorigenesis with an in vivo analysis in Drosophila.
Materials and methods: We selected 15 genes downregulated in two Drosophila cancer models.
Results: The results from the RNAi mini-screen revealed novel roles for the analyzed putative Wnt/β-catenin target genes in tumorigenesis. The downregulation of the analyzed nine genes led to tumor formation as well as metastasis in Drosophila, suggesting a tumor suppressor function. On the other hand, the knockdown of the other two genes suppressed tumor and metastasis formations and disturbed the development of the analyzed eye tissues, indicating an oncogenic or developmental role for these genes.
Conclusion: These findings could serve to identify novel subjects for cancer research in order to provide insight into the diagnostic and therapeutic processes of several cancer types.
Conflict of interest statement
Figures




Similar articles
-
Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.Mol Cancer. 2014 Dec 10;13:261. doi: 10.1186/1476-4598-13-261. Mol Cancer. 2014. PMID: 25491321 Free PMC article.
-
MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway.BMC Cancer. 2018 Jan 8;18(1):60. doi: 10.1186/s12885-017-3960-7. BMC Cancer. 2018. PMID: 29310626 Free PMC article.
-
Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.Oncotarget. 2015 Apr 10;6(10):7866-79. doi: 10.18632/oncotarget.3492. Oncotarget. 2015. PMID: 25797263 Free PMC article.
-
WNT/β-catenin signaling in the development of liver cancers.Biomed Pharmacother. 2020 Dec;132:110851. doi: 10.1016/j.biopha.2020.110851. Epub 2020 Oct 17. Biomed Pharmacother. 2020. PMID: 33080466 Review.
-
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. World J Gastroenterol. 2015. PMID: 26034368 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases